This inventor holds 6 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 9 EPO patents. Top assignees: Ink Invent IP B.v., Aqtis I.p. B.v.. Active years: 2014-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2026
Title: Paul Willem Mijnen: Innovator in Microparticle Technology
Introduction
Paul Willem Mijnen is a notable inventor based in Utrecht, Netherlands. He has made significant contributions to the field of microparticle technology, holding 6 patents that focus on innovative applications of PCL-comprising microparticles.
Latest Patents
Mijnen's latest patents revolve around the invention of microparticles comprising PCL and their various uses. The invention details a process for preparing these microparticles, which can be utilized in creating a gel. This gel has multiple applications, including the preparation of a medicament for treating skin abnormalities or disfigurements. Additionally, it can be used for controlling bladder function, managing gastric reflux, treating erectile dysfunction, and addressing vocal cord issues. The gel also has potential cosmetic applications, showcasing the versatility of Mijnen's innovations.
Career Highlights
Paul Willem Mijnen is associated with Aqtis I.P. B.V., where he continues to develop and refine his innovative ideas. His work in microparticle technology has positioned him as a key figure in this specialized field.
Collaborations
Mijnen collaborates with esteemed colleagues such as Pieter Gerard Zijlstra and Dirk Wybe Grijpma. Their combined expertise contributes to the advancement of research and development in microparticle applications.
Conclusion
Paul Willem Mijnen is a distinguished inventor whose work in microparticle technology has led to significant advancements in medical and cosmetic applications. His contributions continue to impact various fields, demonstrating the importance of innovation in improving health and well-being.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile